The SMARTEX Heart Failure Study

NCT00917046 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 261

Last updated 2019-11-14

No results posted yet for this study

Summary

This protocol describes a randomized multicenter clinical trial designed to test the hypothesis that a 12-week program of high-intensity interval training (HIIT) yields larger beneficial effects in stable heart failure patients than current practice, defined as either a similar training program with the same volume of moderate continuous training (MCT) or a recommendation of regular exercise at moderate intensity at individual choice (RRE).

Conditions

Interventions

BEHAVIORAL

Moderate continuous training

3 weekly sessions of moderate continuous training for 12 weeks

BEHAVIORAL

Recommendation of regular moderate exercise

Recommendation of regular exercise at moderate intensity at individual choice. In addition patients will meet for treadmill walking in order to motivate for post intervention testing

BEHAVIORAL

high-intensity interval training

3 weekly sessions of high-intensity interval training in 12 weeks

Sponsors & Collaborators

  • University Hospital, Antwerp

    collaborator OTHER
  • UMC Utrecht

    collaborator OTHER
  • Technical University of Munich

    collaborator OTHER
  • Heart Center Leipzig - University Hospital

    collaborator OTHER
  • Bispebjerg Hospital

    collaborator OTHER
  • St. Olavs Hospital

    collaborator OTHER
  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Scientific Institute of Veruno

    collaborator UNKNOWN
  • Centre Hospitalier du Luxembourg

    collaborator OTHER
  • Alesund Hospital

    collaborator OTHER
  • Helse Nord-Trøndelag HF

    collaborator OTHER
  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Øyvind Ellingsen, MD, PhD · National Taiwan Normal University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-09-30
Completion
2014-07-31

Countries

  • Belgium
  • Denmark
  • Germany
  • Italy
  • Luxembourg
  • Netherlands
  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00917046 on ClinicalTrials.gov